News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Allergan Inc. (AGN) Accused Of Paying Kickbacks To Spur Eye Drug Sales


12/19/2013 7:33:00 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

A False Claims Act lawsuit unsealed this week accuses aesthetics devices maker Allergan of handing out kickbacks to get doctors to prescribe the company's eye drugs. A pair of Philadelphia ophthalmologists accused medtech company Allergan (NYSE:AGN) of offering doctors illegal kickbacks in exchange for prescriptions of the Allergan's eye drugs. The docs claimed that Allergan explicitly offered to trade prescriptions for consulting services that promised to boost clinic profits and help target patients with "dry eye," according to Corporate Crime Reporter.

Help employers find you! Check out all the jobs and post your resume.


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES